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Abstract
Background The role of vascular risk factors in glaucoma is
still being debated. To assess the importance of vascular
risk factors in patients with primary open-angle glaucoma
(POAG), data from the medical history of 2,879 POAG
patients and 973 age-matched controls were collected and
analyzed.
Methods Design: observational survey. Setting: 35 Italian
academic centers. Study population: POAG patients and
age-matched controls. In order to reduce bias consecutive
patients were included. Observation procedures: data
concerning vascular risk factors were collected for all
patients with a detailed questionnaire. A complete ophthal-
mological examination with assessment of intraocular
pressure (IOP), visual field, optic disc, and systemic blood
pressure was performed. Main outcome measures: the ESH-
ESC (European Society of Hypertension-European Society
of Cardiology) guidelines were used to calculate the level
of cardiovascular risk. Crude and adjusted estimates of the
odds ratios (OR) were calculated for all cardiovascular risk
factors in POAG and controls.
Results The study included 2,879 POAG patients and 973
controls. POAG cases had a significantly higher systolic
and diastolic blood pressure (p=0.001) and systolic
perfusion pressure (p=0.02) as compared with controls.
Also mean IOP was significantly higher in the POAG
group (p=0.01), while diastolic perfusion pressure was not
significantly different in the two groups. Myopia was more
prevalent in the POAG group (23 vs 18%, p=0.005) as well
as a positive family history for glaucoma (26 vs 12%, p=
0.004). POAG patients tended to have a higher cardiovas-
cular risk than controls: 63% of glaucoma cases vs 55% of
controls (OR:1.38, p=0.005) had a “high” or “very high”
cardiovascular risk.
Conclusions The level of cardiovascular risk was signifi-
cantly higher in glaucoma patients than in controls.
Keywords Glaucoma . Risk factors . Survey
Introduction
Primary open-angle glaucoma (POAG) is an optic neuropathy
that is associated in most cases with elevated intraocular
pressure (IOP). Although a number of risk factors, including
elevated IOP, have been described, the pathogenesis leading
to POAG still remains poorly understood [17].
In the past, two theories were proposed: the mechanical
theory in which elevated IOP directly damages the lamina
cribrosa and the neural axons [52], and the vascular theory
in which the optic neuropathy would be a consequence of
insufficient blood supply due to either increased IOP or
other risk factors reducing ocular blood flow [12, 17]. The
two theories may not be mutually exclusive and may
probably interplay in the same patients. There is today
convincing evidence supporting the mechanical theory and
the fundamental role of elevated IOP in glaucoma [7, 11,
17, 25, 27, 29, 42–44, 46], although there are conditions,
such as the low-tension glaucomas, that cannot be
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satisfactorily explained by the mechanical theory alone [4,
13, 17, 32, 37, 45, 49]. The importance of vascular factors
is still being debated and several reviews have summarized
the evidence about the impact of ocular blood flow in
glaucoma [6, 8, 17, 20].
A reduced ocular perfusion in POAG patients compared
with normal subjects was reported in a number of studies,
including large epidemiologic surveys [3, 31, 47]. The
main cause of this reduction would not seem to be
atherosclerosis, but rather a vascular dysregulation, leading
to both low perfusion pressure and insufficient autoregu-
lation [17]. Several vascular risk factors have been
described including atherosclerosis [3, 14, 18, 28, 51],
systemic hypotension [19, 23, 26, 40], reduced perfusion
pressure [3, 31, 47], vasospastic syndromes (primary and
secondary) [15, 16, 38, 39], etc., and their possible role in
glaucomatous optic neuropathy has been hypothesized.
The importance of vascular risk factors has often been
assessed in the context of population studies which,
although including thousands of subjects [3, 31, 47, 51],
were actually evaluating only a few glaucomatous patients.
In order to assess the importance of vascular risk factors, a
national survey of 2,879 POAG patients and 973 age-
matched controls was conducted in 35 academic centers in
Italy (Appendix).
Materials and methods
Study population The study included 3,972 outpatients
aged 50 years or more of both genders. Of these, 2,944
had POAG, while 1,028 served as controls. Written
informed consent was obtained from all patients prior to
their inclusion into the study. The study was approved by
the local Ethics Committees of the centers involved and
conducted in accordance with the Declaration of Helsinki.
POAG was defined as: (a) presence of a glaucomatous
optic disc (i.e., the vertical cup/disc ratio ≥0.7, or the presence
of a “notch” of the optic nerve head rim; consensus of at least
two glaucoma specialists was needed for diagnosis of a
glaucomatous disc); (b) presence of glaucomatous visual field
changes (as tested with the Humphrey 24.2 program), on the
basis of abnormal glaucoma hemifield test and corrected
pattern standard deviation (p<0.05); and (c) open angle
(grades 2–4, Shaffer’s classification). Our definition of
POAG did not consider IOP levels, which were, in most
cases, within the normal range under medical therapy.
Controls were selected among subjects attending the
outpatients clinic and having an IOP<21 mmHg (i.e.,
measured on two consecutive occasions separated by an
interval of at least 2 h but not more than 12 weeks), a
normal optic disc, and a normal visual field.
Main exclusion criteria were (1) the condition of ocular
hypertension (IOP>21 mmHg) without glaucomatous optic
disc and visual field changes, (2) any previous eye surgery
or laser therapy, (3) ocular abnormalities preventing good
assessment of IOP, (4) closed-narrow angle (grades 0–1,
Shaffer’s classification), and (5) proliferating diabetic
retinopathy.
In order to reduce potential bias, all cases and controls were
consecutive patients. Glaucoma patients and controls were
matched (3:1) for age categories (50–55, 56–60, 61–65, etc.).
Study design This was a multicenter (35 academic centers
in Italy) observational study. At inclusion medical history
was obtained, by trained personnel, from each patient with
particular attention to assessment of (cardio)vascular risk
factors. This was done through a detailed questionnaire
including evaluation of life habits, smoking, drinking,
presence of concomitant signs and symptoms or diseases,
concomitant drugs, etc. (a translated copy of the question-
naire is available on request). Blood pressure evaluation
and a complete ophthalmic examination including a visual
field assessment and an IOP diurnal curve were carried out.
Office blood pressure was measured with a mercury
sphygmomanometer three times at 1-min interval after
5 min of rest in the sitting position. Auscultatory systolic
and diastolic values were taken at the time of the 1st and
5th Korotkoff sound, respectively. The average of the three
serial measurements was considered for the analysis.
Measurement of IOP was done by means of the Goldmann
applanation tonometer at the slit-lamp. The average of three
consecutive measurements was considered as the reference
value for IOP in the diurnal curve. The mean of five
tonometric readings (8 A.M., 11 A.M., 2 A.M., 5 A.M., and
8 A.M.) was considered for analysis purposes.
Analysis Only subjects with a complete questionnaire were
included in the analysis.
Since previous studies with a similar design were lacking,
no sample size estimation was feasible. However, based on
prevalence of POAG in previous population studies [3, 31,
47], it was planned to study about 3,000 patients with
glaucoma and 1,000 controls: the number of subjects
recruited (3,792) amounted to 99.3% of planned total.
The questionnaire included a number of questions
addressed to the glaucoma specialists of the academic
centers involved in the study. In particular, the level of the
field damage and the eventual progression of the disease
were carefully investigated. Patients with POAG were
classified into two different subgroups prior to the study
inclusion: one with severe glaucoma (i.e., patients taking
three or more drugs, with severe changes of visual field and
optic disc, i.e., MD<−12 dB, C/D ratio>0.8) and one with
mild to moderate glaucoma (all other cases).
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Continuous variables were summarized by computing
group average, median, standard deviation, and minimum
and maximum or 95% confidence intervals (CI), while
categorical variables were expressed as absolute and
relative frequencies (percentages). Among-groups compar-
isons of office systolic and diastolic blood pressure, average
IOP, as well as systolic and diastolic perfusion pressure
(computed as office systolic or diastolic blood pressure
minus IOP) were made by analysis of variance. In cases of
office systolic and diastolic blood pressure a correction for
age, gender, and presence of systemic hypertension was
also made, with calculation of adjusted least square means.
Among-groups comparisons of rate of subjects with
myopia or family history for POAG was done by the chi-
square test with calculation of odds ratio (OR).
Assessment of cardiovascular risk was primarily based on
the indications of the recent European Society of Hyperten-
sion and European Society of Cardiology Guidelines [10].
The level of office systolic and diastolic blood pressure, the
presence of cardiovascular risk factors (age >55 years for
men, age >65 years for women, smoking, alcohol intake,
poor or null physical activity, dyslipidemia, family history
for cardiovascular diseases), target organ damage, diabetes
mellitus, and associated clinical conditions such as cerebro-
vascular, heart, or peripheral vascular diseases were used for
this purpose. Cardiovascular risk was expressed in terms of
10-year probability of developing cardiovascular diseases
and by identifying five levels of risk: average, low
(probability <15%), moderate (15–20%), high (20–30%),
and very high added (>30%) risk. For all analyses a p≤0.05
was used as the level for statistical significance. All analyses
were performed with SAS (version 7 for Windows, SAS
Institute Inc., Cary, NC, USA).
Results
Patients’ demographics, clinical data, risk factors for
glaucoma and cardiovascular diseases Of the 3,972 en-
rolled subjects, 97% were included in the analysis: 2,879 with
POAG and 973 controls. Data about 65 POAG patients and
55 controls were not sufficiently complete to be included in
the analysis. The demographics, clinical characteristics, and
distribution of risk factors for glaucoma and cardiovascular
diseases of POAG patients and controls are reported in
Table 1. Patients with POAG were slightly, but not
significantly older than controls. Females were slightly more
prevalent in the control group. Patients with severe glaucoma
represented 45% of the whole sample of POAG patients.
Main demographics and clinical data of these two subgroups
of glaucomatous patients are shown in Table 2.
Myopia was significantly more prevalent in the group of
patients with POAG (23 vs 18%, OR:1.46, 95%CI: 1.21–1.76,
p=0.005). Also diabetes, systemic hypertension, cardiovascu-
lar diseases, and to a slightly greater extent hearing
impairment and tinnitus, occurred more frequently in POAG,
but the difference vs controls was not statistically significant
(Table 1). A positive family history for POAG was more
frequently reported by glaucomatous patients (26 vs 12%,
OR:2.81, 95% CI: 2.17–3.65, p=0.004), while the opposite
was true for family history of hypertension (Table 1).
Table 1 Demographics and clinical characteristics of controls and
POAG patients
Controls POAG
(n=973) (n=2,879)
Age (years, mean±sd) 65±10 68±9
Gender (males/females, %) 39/61 45/55
Smoking (%) 15 12
Coffee or tea intake (%) 86 84
Alcohol intake (%) 61 61
Diseases and symptoms (%)
Hypertension 46 48
Dyslipidemia 30 30
Diabetes 13 14
Angina pectoris 6 7
Myocardial infarction 5 4
Heart disease 8 11
TIA 2 3
Cerebral ischemia 3 3
Paralysis or paresis 2 3
Carotid artery stenosis 5 7
Claudicatio intermittens 4 7
Myopia 18 23
Thyroid dysfunction 11 10
Hearing impairment 4 8
Tinnitus 18 22
Headache 15 14
Migraine 5 4
Surgical (vascular) interventions (%) 6 5
Concomitant treatments (%)
Hypertensive drugs 43 45
Lipid-lowering drugs 12 12
Antidiabetic drugs 10 12
Reduced physical activity (%) 67 72
Menopausal status (%) 93 96
Family history of (%)
Myopia 12 12
POAG 12 26
Other types of glaucoma 1 2
Other eye diseases 12 10
Coronary heart disease 34 30
Cerebrovascular disease 23 20
Sudden death 16 13
Hypertension 51 44
Diabetes 33 31
Migraine 15 13
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For all variables no significant differences were observed
between the two subgroups of patients with mild-moderate
and severe glaucoma.
Blood pressure, IOP, and perfusion pressure Systolic and
diastolic blood pressures were slightly, though significantly,
higher in the group of patients with glaucoma (Fig. 1). Mean
systolic blood pressures were 139.2 mmHg (95% CI: 138.4–
139.9 mmHg) in POAG patients vs 137.1 mmHg (95% CI:
136.2–138.1 mmHg) in controls (p=0.001), while mean
diastolic blood pressures were 82.4 mmHg (95% CI: 82.0–
82.8) in POAG patients vs 81.5 mmHg (95% CI: 81.0–
82.1 mmHg) in controls (p=0.001). The small magnitude of
the between-groups difference for systolic and diastolic
blood pressure was evident also after adjustment for
confounding variables, i.e., age, gender, history of hyperten-
sion, and number of antihypertensive medications used.
Mean IOP was also significantly higher in POAG patients
than in controls (16.5 and 15.4 mmHg, respectively, p=
0.01). Mean systolic perfusion pressure was significantly
higher in the POAG group than in controls (122.7mmHg, 95%
CI: 121.8–123.7 mmHg in POAG patients vs 121.7 mmHg,
95% CI: 120.5–122.6 mmHg in controls, p=0.02), but not
diastolic perfusion pressures (65.8 mmHg, 95% CI: 64.9–
66.7 mmHg in POAG patients vs 66.1 mmHg, 95% CI:
65.4–66.6 mmHg in controls, n.s.) (Fig. 1). In any case no
difference was observed for all these parameters between
mild-moderate and severe cases of glaucoma.
Level of cardiovascular risk Patients with POAG showed a
higher level of cardiovascular risk as compared with controls
(Fig. 2). This was evident in the case of very high added risk:
the rate of glaucomatous patients falling in high added or
very high added categories was 63 vs 55% of controls (OR:
1.38, 95% CI: 1.20–1.60, p=0.005). When just the very high
added risk category was considered the OR was 1.73 (95%
CI: 1.58–1.88, p=0.001). No difference in the level of
cardiovascular risk was observed between patients with
mild-moderate glaucoma and patients with severe glaucoma.
Discussion
The main finding of this study is that POAG patients had a
significantly greater added risk than controls when added
Table 2 Demographics and clinical characteristics of POAG patients.
CAI carbonic anhydrase inhibitors
All POAG Mild-mod.
POAG
Severe
POAG
(n=2,879) (n=1,591) (n=1,288)
Age (years, mean±sd) 68±9 66±9 70±9
Gender (males/females, %) 45/55 41/59 50/50
Duration of glaucoma (years,
mean±sd)
7±6 6±6 8±7
POAG progression in the last
5 years (%)
32 17 50
Types of antiglaucomatous
treatment
Alpha 2 agonists 9 6 12
Beta-blockers 70 68 73
Systemic CAIs 5 2 9
Topical CAIs 27 15 41
Parasympathomimetic drugs 4 2 7
Prostaglandin analogues 50 38 66
Others 2 2 2
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Fig. 1 Mean systolic (S) and diastolic (D) blood pressures (BP),
intraocular pressures (IOP), and systolic (S) and diastolic (D)
perfusion pressures (PP) in controls (open bars) and in POAG
patients (black bars). Asterisks: ***p=0.001, **p=0.01, *p=0.02
refer to statistically significant between-groups differences
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risk level was very high, i.e., a 10-year probability of
developing a cardiovascular disease ≥30%.
Several cardiovascular conditions were more prevalent
in the POAG group than in controls. A heart disease was
found in 11% of POAG cases and in 8% of controls, a
carotid stenosis was reported by 7% of glaucoma patients
and by 5% of controls; a “claudicatio intermittens” was
reported by 7% of POAG patients and by 4% of controls; a
hearing impairment was more than twofold prevalent
among glaucoma subjects than among controls (8 vs 4%);
and finally the condition of “cold limbs” was reported by
24% of POAG cases and by 21% of controls. On the other
hand, smoking was less frequent in glaucoma patients than
in controls, and migraine was not more common among
POAG patients. The role played by arteriosclerosis in
glaucoma is unclear. Arteriosclerosis was found to be
associated with POAG in a number of studies, though a
weak relationship was always described [14, 18, 22].
Arteriosclerosis might be associated with an increased
IOP [3, 28, 51], and experimental studies suggest that
ischemia of the endothelial cells lining Schlemm’s canal
might lead to IOP elevation [17, 36]; moreover, arterio-
sclerosis might increase sensitivity of the optic nerve head
to elevated IOP [22]. On the other hand, a number of
conditions related to arteriosclerosis such as smoking,
obesity, hypercholesterolemia, etc. have not been found to
be associated with POAG [17].
The higher level of cardiovascular risk in glaucoma
might also be explained by the fact that POAG patients
showed significantly higher systemic blood pressure values
(both systolic and diastolic) than controls. Although the
difference in blood pressure levels was really small and of
questionable relevance, it reached statistical significance as
in other epidemiologic studies. In a recent report of the
“Blue Mountains Eye Study” [35], systemic hypertension
was found to be modestly, but significantly, associated with
an increased risk of POAG, independently of the effect of
blood pressure on IOP and other glaucoma risk factors. In
particular, systemic hypertension accounted for the greatest
attributable risk for POAG than any other POAG risk
factors found in the study. Other population studies such as
the Rotterdam Study [9] and the Egna-Neumarkt study [3]
found a significant association between POAG and hyper-
tension, while in the Baltimore Eye Survey a nonsignifi-
cantly increased OR was reported [47] and in the Barbados
Study no association was found [31]. There are many
possible pathophysiological mechanisms involved in hy-
pertensive damage to the optic nerve [17, 35]: a chronic
systemic hypertension might cause microvascular damage
with resulting ischemic damage to the anterior optic nerve
structures. In addition, systemic hypertension might modify
the autoregulation of posterior ciliary perfusion to the optic
nerve head, already found impaired in some POAG cases
[21, 48]. Moreover, antihypertensive treatment might
determine some dips particularly at night [19, 23], which
further decrease the amount of blood flow to the optic nerve
and consequently result in additional ischemic damage [17,
24, 35].
A higher systolic perfusion pressure was found in
glaucomatous as compared with non-glaucomatous sub-
jects. This association was also shown in the Blue
Mountains Eye Study [35], in contrast to findings from
both the Baltimore Eye Survey [47] and the Barbados Eye
Study [31]. On the other hand from our study, POAG
patients seemed to have slightly lower diastolic perfusion
pressures, though the difference from controls was not
Fig. 2 Percentages of patients
falling in each of the five cate-
gories of level of cardiovascular
risk. Cardiovascular risk was
expressed in terms of 10-year
probability of developing car-
diovascular diseases and by
identifying five levels of risk:
average, low (probability
<15%), moderate (15–20%),
high (20–30%), and very high
added (>30%) risk. Data are
shown separately for controls
(open bars) and POAG patients
(striped bars)
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significant. Besides, the fact that all POAG patients had
controlled IOP reduced the chance of finding significant
differences from non-glaucomatous cases. The discrepan-
cies reported from the published literature probably arise
from the reduced statistical power in the subgroup analyses
due to the small number of glaucomatous patients in the
population studies [3, 9, 31, 47], but the main confounder
remains probably the strong relationship between systemic
blood pressure and IOP [35].
The condition of myopia was more prevalent in POAG
patients as compared with controls (23 vs 18%). This finding
confirms the results of other papers [33, 41], where myopia
was found to be a significant risk factors for POAG [5].
A family history for POAG was reported by 26% of
POAG patients and by 12% of controls. Although a bias in
reporting [34] might help to explain the difference between
the two groups, family history is probably an important risk
factor for the disease [1, 30, 50], and one of the strongest in
the present study.
Study limitations include the fact that the glaucoma
population in this survey might not be representative of the
“Italian glaucoma population” and the control group might
not be representative of the normal population. As all
observational studies, it is open to a number of confounders
and bias. POAG patients were consecutive cases treated in
academic centers and probably poorly representative of the
average glaucoma cases in the population as they receive
the best diagnostic assessment, treatment, etc. and do not
seem comparable with the POAG patients described in all
of the above-mentioned population surveys [3, 28, 31, 47,
51]. In addition, as some results were based on anamnestic
findings, further bias might arise from recalling. Controls
were selected with the primary feature of not being
glaucomatous, in order to study the cardiovascular risk
factors in glaucoma. Though the presence of glaucoma
could be excluded in these subjects, controls cannot be
considered as representative of the population.
Normal-tension glaucomas (NTG) were part of the
POAG patients (probably less than half of POAG cases
[2]) and were not considered separately as IOP was not an
inclusion criteria. As a consequence, the difference between
POAG and controls in terms of vascular risk factors might
have been diluted by the presence of different types of
glaucoma. NTG have been reported to be associated with a
number of vascular risk factors, in particular systemic
hypotension and vasospasm [17, 19, 23, 24].
In conclusion, POAG patients seem to have an increased
cardiovascular risk, in particular when the risk level is high.
Though significant, this relationship is weak, as expected and
already found in other epidemiologic studies evaluating a small
number of glaucoma cases. A higher systemic blood pressure
was found in POAG patients and might explain the difference
in cardiovascular risk factors from non-glaucomatous cases.
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List of participating centers
University of Bari (Sborgia C, Vetrugno M, Cantatore F),
University of Bologna (Campos E, Baldi A), University of
Brescia (Quaranta L), University of Cagliari (Serra A, Zucca I,
Mura M, Malocci M), University of Catania (Uva M,
Longo A, Lombardo A), University of Catanzaro (Scorcia G,
Moschettini R), University of Chieti (Gallenga PE,
Mastropasqua L, Ciancaglini M, Carpineto P, Lobefalo L),
University of Ferrara (Perri P, Paduano B), University of
Firenze (Alfieri G, Menchini U, Campana F, Giansanti F),
University of Foggia (Delle Noci N, Balducci F), University
of Genova (Calabria G, Saccà S, Sanna G, Camicione P,
Mastromarino A), University of L’Aquila (Balestrazzi E, Di
Staso S), University of Messina (Ferreri G, D’Andrea A),
University of Milano San Paolo (Orzalesi N, Rossetti L,
Fogagnolo P, Mazzolani F), University of Milano San
Raffaele (Brancato R, Carassa R, Bettin P, Fiori M),
University of Modena (Guerra R, Martini E, Scarale G,
Campi L), University of Napoli (Bonavolontà G, Rinaldi E,
Di Meo A, Fusco R), University of Padova (Dorigo MT,
Doro D, Grgic V), University of Palermo (Lodato G,
Morreale Bubella D, Signorelli F), University of Parma
(Gandolfi S), University of Pavia (Trimarchi F, Milano G),
University of Perugia (Fiore C, De Carolis A, Sbordone G),
University of Pisa (Nardi M, Bartolomei MP, Figus M,
Guidi G), University of Roma Policlinico Gemelli
(Scullica L, Salgarello T, Colotto A), University of
Roma Tor Vergata (Bucci MG, Cerulli L, Manni GL,
Centofanti M, Parravano M, Scuderi G, Nucci C),
University of Sassari (Carta F, Pinna A), University of
Siena (Caporossi A, Frezzotti P), University of Torino
(Grignolo F, Brogliatti B, Rolle T), University of Trieste
(Ravalico G, Vattovani O, Tritto D, Canziani T),
University of Verona (Marchini G, Marraffa M)
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